TDOC.NYSETeladoc Health, INC

Form 4: Teladoc Health Executive Nikolaos P. Nanis Reports Stock Transactions

Sentiment:

SEC Form 4 Filing

📋All filings for Teladoc Health, INC
🔒Login to Follow

Nikolaos P. Nanis, Chief Technology Officer of Teladoc Health, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Summary

  • On April 1, 2024, Nikolaos P. Nanis, the Chief Technology Officer of Teladoc Health, had 1,232 restricted stock units vest, which converted into shares of TDOC common stock on a one-for-one basis.
  • Following the vesting, Mr. Nanis sold 461 shares on April 2, 2024, at a price of $14.314 per share to cover tax withholding obligations.
  • After these transactions, Mr. Nanis directly owns 70,621 shares of Teladoc Health common stock and 7,398 restricted stock units.

Sentiment

Score: 5

Explanation: This is a routine insider transaction related to stock-based compensation and doesn't necessarily indicate positive or negative sentiment about the company's future prospects.

Industry Context

This is a routine disclosure of insider transactions, which are common for executives who receive stock-based compensation. It doesn't necessarily reflect a change in the executive's confidence in the company.

Key Dates

DateDescription
October 1, 2022Reporting person was granted 14,793 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
April 1, 20241,232 restricted stock units vested.
April 2, 2024461 shares were sold at $14.314 per share.
April 3, 2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.